Artery embolization for migraines: hope or hype?

NCT ID NCT07652034

Not yet recruiting Knowledge-focused Sponsor: Cortex Neurovascular Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study follows 50 adults with migraines who have had or plan to have a procedure called middle meningeal artery embolization as part of their regular care. Researchers will look at how headache frequency, severity, medication use, and quality of life change over 12 months. The goal is to gather real-world data, not to test the procedure itself.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: middle meningeal artery embolization (procedure)
What this could lead to: If results are promising, this could point toward a larger trial to see if artery embolization is a safe and effective option for migraine relief.
What could go wrong: This is a small, early observational study, not a controlled trial. It cannot prove the procedure works, and results may not apply to all migraine patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHRONIC MIGRAINE HEADACHE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Headache headache disorder migraine disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CHRONIC MIGRAINE HEADACHE MIGRAINE MIGRAINE DISORDERS

Contacts and locations

Locations

Cortex Neurovascular / TRA Union

Tacoma, Washington, 98405, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.